Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 03 Apr 2026 for BioAge Labs, Inc., €19k. Read the official filing
Filing timeline
BuySalePaul d. Rubin
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Paul d. Rubin: trading record in brief
Paul d. Rubin is a declared insider of BioAge Labs, Inc., with filings sourced from SEC (Form 4). Between 4 December 2025 and 1 April 2026, the trades on record add up to 8 filings.
No open-market purchase appears, only 1 sale worth €136k. Other entries cover 7 option exercises. In 2026 alone, the filings show no purchases and 1 sale.
On 3 April 2026 came the latest disclosure, an option exercise for €19k in BioAge Labs, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Paul d. Rubin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
5,437 shares@ US$4.1111.1% of flowCommon StockSEC:0001210905-26-000011:0
3,383 shares@ US$6.5711.0% of flowCommon StockSEC:0001210905-26-000011:1
8,820 shares@ US$17.8177.9% of flowCommon StockSEC:0001210905-26-000011:2
68,897 shares@ US$4.11Common StockSEC:0001210905-25-000004:0
4 of 4 declarations
